These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22000774)

  • 1. Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Bainey KR; Selzer F; Cohen HA; Marroquin OC; Holper EM; Graham MM; Williams DO; Faxon DP
    Am J Cardiol; 2012 Jan; 109(2):195-201. PubMed ID: 22000774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Bangalore S; Vlachos HA; Selzer F; Wilensky RL; Kip KE; Williams DO; Faxon DP
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):22-8. PubMed ID: 20506328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Mulukutla SR; Vlachos HA; Marroquin OC; Selzer F; Holper EM; Abbott JD; Laskey WK; Williams DO; Smith C; Anderson WD; Lee JS; Srinivas V; Kelsey SF; Kip KE
    JACC Cardiovasc Interv; 2008 Apr; 1(2):139-47. PubMed ID: 19212456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).
    Parikh SV; Saya S; Divanji P; Banerjee S; Selzer F; Abbott JD; Naidu SS; Wilensky RL; Faxon DP; Jacobs AK; Holper EM
    Am J Cardiol; 2011 Apr; 107(7):959-64. PubMed ID: 21256469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group.
    Brodie BR; Stuckey T; Downey W; Humphrey A; Nussbaum M; Laurent S; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):893-900. PubMed ID: 19016465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.
    Parikh SV; Luna M; Selzer F; Marroquin OC; Mulukutla SR; Abbott JD; Holper EM
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):192-200. PubMed ID: 21735515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.
    Patel MR; Marso SP; Dai D; Anstrom KJ; Shunk KA; Curtus JP; Brennan JM; Sedrakyan A; Messenger JC; Douglas PS
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1054-61. PubMed ID: 23078736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Vasaiwala S; Vlachos H; Selzer F; Marroquin O; Mulukutla S; Abbott JD; Williams DO
    Am J Cardiol; 2012 Oct; 110(8):1113-8. PubMed ID: 22762712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry.
    Olafiranye O; Vlachos H; Mulukutla SR; Marroquin OC; Selzer F; Kelsey SF; Williams DO; Strollo PJ; Reis SE; Lee JS; Smith AJC
    Int J Cardiol; 2015 Apr; 184():79-85. PubMed ID: 25697874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ; Sattur S; Orshaw P; Boura J
    J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
    Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.
    Venkitachalam L; Kip KE; Selzer F; Wilensky RL; Slater J; Mulukutla SR; Marroquin OC; Block PC; Williams DO; Kelsey SF;
    Circ Cardiovasc Interv; 2009 Feb; 2(1):6-13. PubMed ID: 20031687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
    Hannan EL; Racz M; Walford G; Holmes DR; Jones RH; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2008 Apr; 1(2):129-35. PubMed ID: 19463290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents in patients with chronic kidney disease: a prospective registry study.
    Shenoy C; Boura J; Orshaw P; Harjai KJ
    PLoS One; 2010 Nov; 5(11):e15070. PubMed ID: 21124771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.